patent expiry for GLP-1 drugs across markets Company Molecule Brand Name Mode of administration First US Patent Expiry Canada Brazil India Novo Semaglutide Ozempic Injectable 2031 Jan 2026 Mar 2026 Mar 2026 Novo Semaglutide Wegovy Injectable 2031 Jan 2026 Mar 2026 Mar 2026 Novo Semaglutide Rybelsus Oral 2031 Jan 2026 Mar 2026 Mar 2026 Eli Lilly Tirzepatide Mounjaro Injectable 2036 2036 2036 2036 Eli Lilly Tirzepatide Zepbound Injectable 2036 2036 2036 2036 Positioning of Indian Pharma companies in GLP-1s company positioning Shaily Engineering Leading manufacturer of pen injectors for GLP-1 therapies
Special Conditions Require Attention- Those with specific conditions such as eye problems, Lebers disease, kidney or liver disease, iron or folic acid deficiency, infections, or undergoing bone marrow-affecting treatments should seek professional advice
Walk into our clinic for the best treatment for stretch marks to reveal a new, stretch-mark-free you!
Guided sessions for cravings, sleep, and the emotional weather of the journey
The challenge isnt creating more GLP-1its understanding how to activate the cells that produce it and protect the hormone from rapid degradation